文献速递关节外科运动医学

富血小板血浆对软骨细胞衰老及膝骨关节炎进展的影响

Effects of Platelet-Rich Plasma on Chondrocyte Senescence and Knee Osteoarthritis Progression.
PubMed 文献 · Am J Sports Med · 2026-01-26

该研究通过体外实验和鼠膝骨关节炎模型,评估富血小板血浆对软骨细胞衰老的调控作用及对骨关节炎进展的影响。体外实验显示富血小板血浆抑制软骨细胞衰老和细胞外基质退变,改善线粒体功能;体内实验显示关节腔内注射富血小板血浆修复受损关节软骨、改善骨小梁参数并抑制衰老相关蛋白表达。作者认为富血小板血浆可能通过抑制软骨细胞衰老来减缓骨关节炎进展。

要点

  • 体外实验显示富血小板血浆抑制软骨细胞衰老和细胞外基质退变,并改善线粒体功能。
  • 大鼠膝骨关节炎模型中,关节腔内注射富血小板血浆修复受损关节软骨并抑制衰老相关蛋白表达。
  • 作者认为富血小板血浆可能通过抑制软骨细胞衰老来减缓骨关节炎进展。

核心结论

  • 作者认为富血小板血浆可能通过抑制软骨细胞衰老来减缓骨关节炎进展。
  • 该研究为富血小板血浆治疗骨关节炎的临床应用提供了新的理论基础和实验支持。

研究设计与样本

  • 对照实验室研究,包括体外软骨细胞实验和大鼠膝骨关节炎模型。
  • 大鼠膝骨关节炎模型通过前交叉韧带横断建立,随后每周关节腔内注射富血小板血浆或磷酸盐缓冲液,持续4周。
  • 术后第8周和第12周收集膝关节样本进行大体形态、影像学和组织学分析。

主要发现

  • 体外实验显示富血小板血浆抑制软骨细胞衰老和细胞外基质退变,表现为II型胶原α1链和聚集蛋白聚糖表达增加,基质金属蛋白酶13、含血小板反应蛋白基序的解整合素和金属蛋白酶5、细胞周期蛋白依赖性激酶抑制剂2A、细胞周期蛋白依赖性激酶抑制剂1A和肿瘤蛋白p53表达降低。
  • 体外实验还显示富血小板血浆抑制白细胞介素1β、白细胞介素6和肿瘤坏死因子的信使核糖核酸表达以及β-半乳糖苷酶阳性。
  • 体外实验显示富血小板血浆调节细胞周期停滞、改善线粒体功能并增强抗氧化特性。
  • 体内实验显示关节腔内注射富血小板血浆修复受损关节软骨、改善骨小梁参数并上调II型胶原α1链和聚集蛋白聚糖表达,同时抑制膝骨关节炎模型软骨中衰老相关蛋白P16、P21和P53的表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Knee osteoarthritis (KOA) is a common degenerative disease characterized by cartilage degradation and damage. Chondrocyte senescence plays a key role in disease progression, as the accumulation of senescent cells disrupts cellular function and exacerbates cartilage damage. Platelet-rich plasma (PRP), rich in growth factors, promotes tissue repair and regeneration. It remains unclear whether platelet-rich plasma modulates cellular senescence to regulate the progression of knee osteoarthritis. PURPOSE: To evaluate the effects of PRP on chondrocyte senescence in KOA and investigate its potential underlying mechanisms. STUDY DESIGN: Controlled laboratory study. METHODS: Chondrocyte cell cycle, senescence markers, senescence-associated secretory phenotype secretion, and extracellular matrix integrity were evaluated by Western blot, real-time quantitative polymerase chain reaction, flow cytometry, immunofluorescence, and β-galactosidase staining. Mitochondrial function and antioxidative properties were assessed by measuring mitochondrial membrane potential and reactive oxygen species levels. Additionally, a rat KOA model was established by anterior cruciate ligament transection, followed by weekly intra-articular injections of PRP or phosphate-buffered saline for 4 weeks. Knee joint samples were collected at 8 and 12 weeks after surgery for gross morphology, imaging, and histological analysis. RESULTS: In vitro experiments revealed that PRP inhibited chondrocyte senescence and extracellular matrix degeneration, as evidenced by increased expression of collagen type 2 alpha 1 (COL2A1) and aggrecan (ACAN), and decreased expression of matrix metalloproteinase 13 (MMP13), a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5), cyclin-dependent kinase inhibitor 2A (P16), cyclin-dependent kinase inhibitor 1A (P21), and tumor protein p53 (P53). Additionally, messenger ribonucleic acid (mRNA) expression of interleukin-1β (Il1b), interleukin-6 (Il6), and tumor necrosis factor (TNF), as well as β-galactosidase positivity, was suppressed. Furthermore, PRP was found to modulate cell cycle arrest, improve mitochondrial function, and enhance antioxidative properties. In vivo experiments demonstrated that intra-articular PRP injection repaired damaged articular cartilage, improved trabecular bone parameters, and upregulated the expression of COL2A1 and ACAN, while suppressing the expression of senescence-related proteins P16, P21, and P53 in the cartilage of the KOA model. CONCLUSION: Our results demonstrated that PRP may slow osteoarthritis progression by inhibiting chondrocyte senescence. CLINICAL RELEVANCE: Chondrocyte senescence plays a critical role in the pathogenesis of osteoarthritis. This study provides new theoretical foundations and experimental support for the clinical application of PRP in the treatment of osteoarthritis.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Zhang JY, Xiang XN, Wang XX, et al. Effects of Platelet-Rich Plasma on Chondrocyte Senescence and Knee Osteoarthritis Progression. Am J Sports Med. 2026. PMID: 41588810. doi:10.1177/03635465251408090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。